Nomura Research Institute, Ltd. (NRILY)
USD 38.19
(2.06%)
USD 38.19
(2.06%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 142.27 Billion | 118.89 Billion | 98.13 Billion | 84.59 Billion | 112.83 Billion | 56.34 Billion |
| Net Income | 79.64 Billion | 76.3 Billion | 71.44 Billion | 52.86 Billion | 58.19 Billion | 50.93 Billion |
| Depreciation & Amortization | 48.15 Billion | 45.09 Billion | 41.94 Billion | 40.91 Billion | 39.38 Billion | 34.35 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 4.13 Billion | 7.68 Billion | -26.04 Billion | -8.57 Billion | 1.59 Billion | -11.01 Billion |
| Other non-cash items | 114.63 Billion | -10.18 Billion | 10.79 Billion | -609 Million | 13.66 Billion | -17.92 Billion |
| Investing Cash Flow | -53.42 Billion | -61.19 Billion | -130.54 Billion | -31.84 Billion | 18.38 Billion | -16.82 Billion |
| Investments in PPE | -49.79 Billion | -54.7 Billion | -42.97 Billion | -29.02 Billion | -27.4 Billion | -25.5 Billion |
| Acquisitions | -4.02 Billion | -1.87 Billion | -64.72 Billion | -11.31 Billion | 230 Million | 954 Million |
| Investment purchases | -1.99 Billion | -9.41 Billion | -8.26 Billion | -2.47 Billion | -5.7 Billion | -19.85 Billion |
| Sales/Maturities of investments | 2.07 Billion | 5.38 Billion | 2.1 Billion | 11 Billion | 50.87 Billion | 27.61 Billion |
| Other Investing Activities | 329 Million | -584 Million | -16.68 Billion | -28 Million | 385 Million | -39 Million |
| Financing Cash Flow | -47.57 Billion | -44.92 Billion | -7.99 Billion | -1.85 Billion | -149.9 Billion | -73.1 Billion |
| Debt repayment | -55.81 Billion | -9.66 Billion | -81.49 Billion | -12.92 Billion | -44.5 Billion | -21.45 Billion |
| Dividends payments | -27.58 Billion | -25.37 Billion | -22.64 Billion | -20.3 Billion | -19.39 Billion | -21.37 Billion |
| Common Stock Repurchased | -68.42 Billion | -20.15 Billion | -60.13 Billion | -10 Billion | -171.05 Billion | -36.78 Billion |
| Common Stock Issuance | 5.03 Billion | 22.72 Billion | 6.75 Billion | 27.38 Billion | 6.93 Billion | 6.64 Billion |
| Other Financing Activities | -688 Million | -12.44 Billion | 149.53 Billion | 13.99 Billion | 78.12 Billion | -135 Million |
| Accounts receivables | -7.52 Billion | -904 Million | -14.58 Billion | -9.91 Billion | 4.2 Billion | -14.78 Billion |
| Accounts payables | -574 Million | 1.54 Billion | 1.35 Billion | 4.27 Billion | -5.07 Billion | 5.24 Billion |
| Inventory | 109 Million | -276 Million | 213 Million | 399 Million | -343 Million | -1.04 Billion |
| Other working capital | 12.12 Billion | 7.32 Billion | -13.02 Billion | -3.33 Billion | 2.8 Billion | -425 Million |
| Cash at beginning of period | 129.25 Billion | 115.61 Billion | 153.18 Billion | 100.77 Billion | 123.2 Billion | 158.3 Billion |
| Cash at end of period | 173.93 Billion | 129.25 Billion | 115.61 Billion | 153.18 Billion | 100.77 Billion | 123.2 Billion |
| Capital Expenditure | -49.79 Billion | -54.7 Billion | -42.97 Billion | -29.02 Billion | -27.4 Billion | -25.5 Billion |
| Effect of forex changes on cash | 3.39 Billion | 859 Million | 2.82 Billion | 1.52 Billion | -3.73 Billion | -1.51 Billion |
| Net cash flow / Change in cash | 44.67 Billion | 13.64 Billion | -37.57 Billion | 52.4 Billion | -22.42 Billion | -35.1 Billion |
| Free Cash Flow | 92.48 Billion | 64.19 Billion | 55.16 Billion | 55.56 Billion | 85.43 Billion | 30.84 Billion |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 79.64 Billion | 18.55 Billion | 23.43 Billion | 20.45 Billion | 17.21 Billion | 76.3 Billion |
| Depreciation & Amortization | 48.15 Billion | 12.09 Billion | 12.3 Billion | 12.03 Billion | 11.71 Billion | 45.09 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 4.13 Billion | 1.17 Billion | 1.07 Billion | -16.6 Billion | 18.49 Billion | 7.68 Billion |
| Other non-cash items | 114.63 Billion | 37.33 Billion | -5.08 Billion | 8.63 Billion | -3.93 Billion | -10.18 Billion |
| Investing Cash Flow | -53.42 Billion | -9.74 Billion | -11.99 Billion | -15.25 Billion | -16.43 Billion | -61.19 Billion |
| Investments in PPE | -49.79 Billion | -10.16 Billion | -11.88 Billion | -11.83 Billion | -15.91 Billion | -54.7 Billion |
| Acquisitions | -4.02 Billion | 515 Million | -7 Million | -3.99 Billion | -543 Million | -1.87 Billion |
| Investment purchases | -1.99 Billion | -440 Million | -112 Million | -434 Million | -1.01 Billion | -9.41 Billion |
| Sales/Maturities of investments | 2.07 Billion | 382 Million | -417 Million | 1.04 Billion | 1.06 Billion | 5.38 Billion |
| Other Investing Activities | 329 Million | -42 Million | 431 Million | -38 Million | -22 Million | -584 Million |
| Financing Cash Flow | -47.57 Billion | -4.54 Billion | 64 Million | -22.2 Billion | -20.88 Billion | -44.92 Billion |
| Debt repayment | -55.81 Billion | -2.99 Billion | -37.25 Billion | -8.78 Billion | -12.76 Billion | -9.66 Billion |
| Dividends payments | -27.58 Billion | -1 Million | -13.93 Billion | -29 Million | -13.67 Billion | -25.37 Billion |
| Common Stock Repurchased | -68.42 Billion | -1 Million | -22.62 Billion | -28.69 Billion | -17.1 Billion | -20.15 Billion |
| Common Stock Issuance | 5.03 Billion | 1.85 Billion | 2.25 Billion | 766 Million | 157 Million | 22.72 Billion |
| Other Financing Activities | -688 Million | -555 Million | 71.62 Billion | 14.53 Billion | 22.5 Billion | -12.44 Billion |
| Accounts receivables | -7.52 Billion | -23.67 Billion | 8.48 Billion | -24.29 Billion | 31.95 Billion | -904 Million |
| Accounts payables | -574 Million | 21.23 Billion | -5.29 Billion | -1.53 Billion | -14.97 Billion | 1.54 Billion |
| Inventory | 109 Million | 19 Million | -379 Million | -57 Million | 526 Million | -276 Million |
| Other working capital | 12.12 Billion | 3.59 Billion | -1.73 Billion | 9.28 Billion | 980 Million | 7.32 Billion |
| Cash at beginning of period | 129.25 Billion | 144.3 Billion | 125.2 Billion | 137.34 Billion | 129.25 Billion | 115.61 Billion |
| Cash at end of period | 173.93 Billion | 173.93 Billion | 144.3 Billion | 125.2 Billion | 137.34 Billion | 129.25 Billion |
| Capital Expenditure | -49.79 Billion | -10.16 Billion | -11.88 Billion | -11.83 Billion | -15.91 Billion | -54.7 Billion |
| Effect of forex changes on cash | 3.39 Billion | 1.37 Billion | -702 Million | 804 Million | 1.92 Billion | 859 Million |
| Net cash flow / Change in cash | 44.67 Billion | 29.63 Billion | 19.09 Billion | -12.13 Billion | 8.09 Billion | 13.64 Billion |
| Free Cash Flow | 92.48 Billion | 32.38 Billion | 19.83 Billion | 12.68 Billion | 27.57 Billion | 64.19 Billion |
7827
BIOKA
CKNHF
000717
AGM-A
PRVU